ETF128

SKU
ETF128
Log In To Order
In stock

Vendor Options


Vendor Options

Price Quantity  

Product Description


Early-stage Diabetic Peripheral Neuropathy Diagnosis

O’Brien Medical introduces the ETF128, an exciting new instrument for the neurodiagnostics market. The ETF128   is now commercially available after a five year development and testing process.

Physicians have long known that 128 Hz tuning fork is the most sensitive of the commonly used neurological screening tests available in clinical practice. The ETF¹²_(Electronic Tuning Fork/128 Hz) builds on this foundation and takes it to the next level. The ETF does this by electronically reproducing the most valuable features of the traditional tuning fork.

Improved Prevention for Limb Loss

The improved accuracy and reproducibility afforded by this approach has been combined with an integrated timing function. The result is a modern medical instrument allowing physicians to diagnose diabetic peripheral neuropathy (DPN) at earlier stages. Prompt diagnosis of this condition is critical as neuropathy is known to be the key precursor leading to foot ulcers, infections and amputations. Armed with the ETF, physicians will be able to more rapidly implement preventative strategies aimed at reducing limb loss.

  • First medical-grade 128 Hz Electronic Tuning Fork
  • Ideal for risk stratification and tracking of pedal DPN, entrapment neuropathy, fall risk, pre-/post-operative nerve release
  • Standardized timed vibration testing between patients and providers
  • Quantitative documentation for EMR requirements
  • Five vibration amplitude modes: Descending, Ascending, Constant, Fx Test and Vibroception Average*
  • Simple ergonomic design

*Average of ascending and descending vibration amplitudes

Specifications

  • Manufacturer #: ETF128
  • Supplier: Medrano & Associates LLC
  • Age: Adult
  • Contains Latex: No
  • Sterile: No
  • Manufacturer: Medrano & Associates LLC
  • RX License Required: No
  • Unit of Measure: Each
COPYRIGHT© 2022 DOCSHOP PRO | ALL RIGHTS RESERVED.